Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South.
Open Forum Infect Dis
; 9(9): ofac455, 2022 Sep.
Article
en En
| MEDLINE
| ID: mdl-36147599
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Open Forum Infect Dis
Año:
2022
Tipo del documento:
Article